Share on Facebook
Share on Twitter
Share on LinkedIn

Sept 11 (Reuters) – Medtronic Plc on Monday said that it would recall certain infusion sets used with all its insulin pumps due to a discontinued component.

The company said the component, a vent membrane, in the recalled infusion sets could be blocked by fluid during the process of priming, or removal of air bubbles. (Reporting by Manas Mishra in Bengaluru; Editing by Savio D‘Souza)

Read More